Label‐Free Quantitative Proteomics Identifies Novel Biomarkers for Distinguishing Tuberculosis Pleural Effusion from Malignant Pleural Effusion-Reference-Cited by-同舟云学术

Label‐Free Quantitative Proteomics Identifies Novel Biomarkers for Distinguishing Tuberculosis Pleural Effusion from Malignant Pleural Effusion

Published:2019-11-24 Issue:1 Volume:14 Page:1900001
ISSN:1862-8346
Container-title:PROTEOMICS – Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Pan Liping¹,Zhang Xia¹,Jia Hongyan¹,Huang Mailing²,Liu Fei²,Wang Jinghui³,Du Boping¹,Wei Rongrong¹,Sun Qi¹,Xing Aiying¹,Li Qi²,Zhang Zongde¹^ORCID

Affiliation:

1. Beijing Chest Hospital, Capital Medical University; Beijing Key Laboratory for Drug Resistant Tuberculosis ResearchBeijing Tuberculosis and Thoracic Tumor Research Institute Beijing 101149 China

2. Department of Tuberculosis, Beijing Chest Hospital Capital Medical UniversityBeijing Tuberculosis and Thoracic Tumor Research Institute Beijing 101149 China

3. Department of Medical Oncology, Beijing Chest Hospital Capital Medical UniversityBeijing Tuberculosis and Thoracic Tumor Research Institute Beijing 101149 China

Funder

Natural Science Foundation of Beijing Municipality

Beijing Nova Program

National Natural Science Foundation of China

Publisher

Wiley

Subject

Clinical Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prca.201900001

Reference36 articles.

1. Pleural Disease